Caxton Associates (New York)’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-32,554
| Closed | -$426K | – | 531 |
|
|
2022
Q1 | $426K | Hold |
32,554
| – | – | 0.03% | 263 |
|
|
2021
Q4 | $573K | Buy |
32,554
+20,069
| +161% | +$353K | 0.06% | 225 |
|
|
2021
Q3 | $271K | Buy |
12,485
+9,663
| +342% | +$210K | 0.03% | 316 |
|
|
2021
Q2 | $99K | Buy |
+2,822
| New | +$99K | 0.01% | 427 |
|
|
2020
Q2 | – | Sell |
-2,657
| Closed | -$260K | – | 431 |
|
|
2020
Q1 | $260K | Buy |
+2,657
| New | +$260K | 0.05% | 285 |
|